Market Review

The fourth quarter began with investors still on edge with a lot of uncertainty from the looming presidential election, rising case counts again here in the U.S., and a second spike in cases across Europe. The markets endured a politically charged environment post-election, record case counts, additional targeted economic shutdowns, and cheered the approvals of the first COVID-19 vaccines. The markets finished 2020 with a huge post-election rally that took risk assets to new all-time highs.

The market has broadened out since the COVID-19 vaccine announcements. The combination of clear Fed and fiscal policy along with the likelihood of improved mobility due to the vaccination rollout in the first half of 2021 has been met with corporate revenues and earnings exceeding expectations at record rates.

Cyclicals continue to perform well with the expectation of increased economic activity in 2021. This positive momentum was reinforced by Congress approving a $900 billion COVID-19 relief package and the FOMC offering guidance about its purchases of Treasuries and mortgage-backed securities by linking the purchase program to economic conditions.

Risk assets surged during the quarter, with the S&P 500 gaining 12.14%, the Russell 2000 surging 31.36%, the MSCI ACWI ex-US Index up 17.01%, and the Bloomberg Barclays U.S. Corporate High Yield Index up 6.45%. It was a remarkable quarter to close out a very strong year for the markets, with each of those indices closing at all-time highs.

Fourth Quarter Performance Highlights

For the quarter, Fixed Income Total Return slightly underperformed the Bloomberg Barclays U.S. Corporate High Yield Index (gross and net of fees) and outperformed the Bloomberg Barclays U.S. Aggregate Bond Index (gross and net of fees). For the calendar year 2020, the strategy outperformed both the Bloomberg Barclays U.S. Corporate High Yield Index (gross and net of fees) and the Bloomberg Barclays U.S. Aggregate Bond Index (gross and net of fees).

  • The strategy remained fully invested in high yield bonds throughout the fourth quarter and enters the New Year with a risk-on bias. Strong post-election gains and optimism of vaccine approvals have high yield bonds trading at all-time highs. The risk-on bias for the quarter is evident by the performance spread between high yield bonds and Treasuries. For the quarter, the Bloomberg Barclays U.S. Corporate High Yield Index gained 6.45% while the Bloomberg Barclays 7-10 Year Treasury Index declined 1.31%.
  • High yield spreads ended the year at 360 basis points, a post-pandemic low, and a strong improvement from the 1100 basis point spread at the depth of the declines in March. The steady grind lower in corporate credit spreads has continued virtually unabated since the March lows. We expect that credit spreads will continue to inch toward their pre-pandemic levels.
  • Low macro volatility following recent positive vaccine developments and the accommodative stance of monetary policy should support credit risk appetite. Valuations limit long-term upside relative to the stellar performance since late March, but credit will likely deliver decent excess returns and solid Sharpe ratios in 2021.

Positioning and Outlook

There are a lot of positive influences on the economy right now including strong economic momentum, an unprecedented amount of monetary and fiscal stimulus, a booming housing market, pent up demand for spending, inventory rebuilding, and the COVID vaccines roll out. We expect 5% economic growth in 2021, and given the potential for additional fiscal spending with Democrats controlling D.C., we could see an upside surprise.

We will continue to see monetary and fiscal policy support to prop up asset prices, which is a global phenomenon. The yield curve has steepened with short rates anchored and longer-term rates drifting higher. The 10-year Treasury yield recently broke above 1.0% after falling to an all-time low of 0.50% on March 9th. We can easily see a scenario where market yields continue to gradually rise given continued economic growth and pent-up demand for spending once the pandemic is behind us. Now with the 10-year yield breaking through 1.0%, we could see a run towards 1.5%, which is the next level of technical resistance.

In our opinion, the main risks to the outlook include excessive short-term investor sentiment, lofty equity market valuations, an unexpected rise in inflation, a slower-than-expected vaccine rollout, and potential policy changes from a unified Democratic control in D.C., including tax hikes. Our sense is that concerns about higher tax rates and increased regulation will likely start to weigh on the market at some point, but the economy and market will get a cyclical boost from additional fiscal spending.

The views expressed are those of the author(s) and do not necessarily reflect the views of Clark Capital Management Group. The opinions referenced are as of the date of publication and are subject to change due to changes in the market or economic conditions and may not necessarily come to pass. There is no guarantee of the future performance of any Clark Capital investments portfolio. Material presented has been derived from sources considered to be reliable, but the accuracy and completeness cannot be guaranteed. Nothing herein should be construed as a solicitation, recommendation or an offer to buy, sell or hold any securities, other investments or to adopt any investment strategy or strategies. For educational use only. This information is not intended to serve as investment advice. This material is not intended to be relied upon as a forecast or research. The investment or strategy discussed may not be suitable for all investors. Investors must make their own decisions based on their specific investment objectives and financial circumstances. Past performance does not guarantee future results.
This document may contain certain information that constitutes forward-looking statements which can be identified by the use of forward-looking terminology such as “may,” “expect,” “will,” “hope,” “forecast,” “intend,” “target,” “believe,” and/or comparable terminology (or the negative thereof). Forward looking statements cannot be guaranteed. No assurance, representation, or warranty is made by any person that any of Clark Capital’s assumptions, expectations, objectives, and/or goals will be achieved. Nothing contained in this document may be relied upon as a guarantee, promise, assurance, or representation as to the future.
S&P Global Ratings issue credit rating is a forward-looking opinion about the creditworthiness of an obligor with respect to a specific financial obligation, a specific class of financial obligations, or a specific financial program (including ratings on medium-term note programs and commercial paper programs). It takes into consideration the creditworthiness of guarantors, insurers, or other forms of credit enhancement on the obligation and takes into account the currency in which the obligation is denominated. The opinion reflects S&P Global Ratings’ view of the obligor’s capacity and willingness to meet its financial commitment as they come due, and this opinion may assess terms, such as collateral security and subordination, which could affect ultimate payment in the event of default.
The S&P 500 measures the performance of the 500 leading companies in leading industries of the U.S. economy, capturing 75% of U.S. equities.
A S&P ‘BBB’ rated obligation exhibits adequate protection parameters. However, adverse economic conditions or changing circumstances are more likely to weaken the obligor’s capacity to meet its financial commitments on the obligation.
Fixed Income securities are subject ro certain risks including, but not limited to: interest rate (changes in interest rates may cause a decline in market value or an investment), credit, prepayment, call (some bonds allow the issuer to call a bond for redemption before it matures), and extension (principal repayments may not occur as quickly anticipated, causing the expected maturity of a security to increase).
Non-investment trade debt securities (high yield/junk bonds) may be subject to greater market flunctuations, risk of default or loss of income and principal than higher-rated securities.
The Bloomberg Barclays US Treasury Index measures US dollar-denominated, fixed-rate, nominal debt issued by the U.S. Treasury.
The Bloomberg Barclays US Corporate High Yield Bond Index measures the USD-denominated, high yield, fixed-rate corporate bond market. Securities are classified as high yield if the middle rating of Moody’s, Fitch and S&P is Ba1/BB+/BB+ or below.
The Bloomberg Barclays U.S. Corporate High-Yield Index covers the U.S. dollar-denominated, non-investment grade, fixed-rate, taxable corporate bond market. Securities are classified as high-yield if the middle rating of Moody’s, Fitch, and S&P is Ba1/BB+/BB+ or below.
Bloomberg Barclays U.S. Aggregate Bond Index: The index is unmanaged and measures the performance of the investment grade, U.S. dollar denominated, fixed-rate taxable bond market, including Treasuries and government-related and corporate securities that have a remaining maturity of at least one year.
Clark Capital Management Group, Inc. reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. The information provided in this report should not be considered a recommendation to purchase or sell any particular security, sector or industry. There is no assurance that any securities, sectors or industries discussed herein will be included in an account’s portfolio.
Clark Capital Management Group, Inc. is an investment adviser registered with the U.S. Securities and Exchange Commission. Registration does not imply a certain level of skill or training. More information about Clark Capital’s advisory services and fees can be found in its Form ADV which is available upon request.
CCM-505

downloadPDF